Please check your internet connection and try again.
# Penicillin prophylaxis for Acute rheumatic fever
## Overview
- **Classification**: Beta-lactam antibiotic, Penicillin class.
- **Mechanism**: Inhibits bacterial cell wall synthesis by interfering with peptidoglycan cross-linking, leading to bacterial lysis.
## Primary Indications
1. **Secondary Prophylaxis of Acute Rheumatic Fever (ARF)** - Prevention of recurrent episodes of ARF in individuals with a history of ARF.
2. **Primary Prevention of ARF** - Treatment of Group A Streptococcal (GAS) pharyngitis to prevent a first episode of ARF.
## Adult Dosing
### Standard Dosing
**Secondary Prophylaxis of ARF**
- **Dose**: **1.2 million units**
- **Frequency**: Every **3 weeks** (preferred) or **4 weeks**
- **Route**: Deep Intramuscular (IM) injection (Benzathine Penicillin G)
- **Duration**: Long-term; depends on severity of initial ARF episode (e.g., 5 years, 10 years, or lifelong).
**Alternative for Secondary Prophylaxis (Oral)**
- **Dose**: **250 mg** (Penicillin V)
- **Frequency**: **Twice daily** (BID) or **500 mg once daily** (QD)
- **Route**: Oral (PO)
- **Duration**: Long-term, same as IM.
### Dose Adjustments
- **Renal Impairment**: Penicillin G elimination is primarily renal. For prophylaxis, frequency adjustments are rarely needed due to long dosing intervals. For severe impairment (CrCl <10 mL/min), monitor for accumulation if dose interval shortens or higher doses given.
- **Hepatic Impairment**: No specific adjustments required.
- **Elderly Patients**: Generally, no specific dose adjustments based solely on age; use caution with renal impairment, common in elderly.
## Pediatric Dosing
### Neonates (0-28 days)
- ARF prophylaxis is **not typically indicated** for this age group as ARF is extremely rare in neonates.
### Infants (1-12 months)
- ARF prophylaxis is **not typically indicated** for this age group as ARF is very rare in infants.
### Children (1-12 years)
**Secondary Prophylaxis of ARF**
- **Dose (<27 kg)**: **600,000 units**
- **Dose (≥27 kg)**: **1.2 million units**
- **Frequency**: Every **3 weeks** (preferred) or **4 weeks**
- **Route**: Deep Intramuscular (IM) injection (Benzathine Penicillin G)
- **Maximum**: **1.2 million units** per dose.
- **Special Notes**: Consider IM route for compliance, especially long-term.
**Alternative for Secondary Prophylaxis (Oral)**
- **Dose**: **250 mg** (Penicillin V)
- **Frequency**: **Twice daily** (BID)
- **Route**: Oral (PO)
- **Special Notes**: Compliance is critical for efficacy; IM route often preferred for reliability.
### Adolescents (13-18 years)
**Secondary Prophylaxis of ARF**
- **Dose**: **1.2 million units**
- **Frequency**: Every **3 weeks** (preferred) or **4 weeks**
- **Route**: Deep Intramuscular (IM) injection (Benzathine Penicillin G)
- **Maximum**: **1.2 million units** per dose.
**Alternative for Secondary Prophylaxis (Oral)**
- **Dose**: **250 mg** (Penicillin V)
- **Frequency**: **Twice daily** (BID) or **500 mg once daily** (QD)
- **Route**: Oral (PO)
## Safety Information
### Contraindications
- **Absolute**: History of severe hypersensitivity reaction to penicillin (e.g., anaphylaxis, Stevens-Johnson syndrome).
- **Absolute**: History of severe hypersensitivity reaction to cephalosporins (potential cross-reactivity).
### Common Adverse Effects
- **Common (1-10%)**: Injection site pain, swelling, tenderness (IM route).
- **Common (1-10%)**: Nausea, vomiting, diarrhea (oral route).
- **Common (1-10%)**: Rash, urticaria (mild allergic reactions).
- **Serious but Rare**: Anaphylaxis, angioedema, serum sickness-like reaction. Monitor for signs of severe allergic reaction immediately post-administration.
### Key Drug Interactions
- **Probenecid**: Decreases renal tubular secretion of penicillin, increasing penicillin serum levels. Clinical significance for prophylaxis is usually low but may be used therapeutically.
- **Methotrexate**: Penicillin may reduce methotrexate elimination, increasing toxicity. Monitor methotrexate levels.
- **Live Typhoid Vaccine**: Antibiotics may reduce effectiveness; administer typhoid vaccine at least 3 days after stopping penicillin.
## Monitoring & Follow-up
- **Before Treatment**: Assess for penicillin allergy history.
- **During Treatment**:
- Observe for signs of allergic reaction, especially after IM injection.
- Monitor for adherence to regimen, critical for efficacy.
- Regular clinical follow-up for ARF recurrence (e.g., symptoms, echo if indicated).
- **Clinical Signs**: Patient education on symptoms of GAS pharyngitis (sore throat, fever) and ARF recurrence (joint pain, rash, fever, fatigue).
## Clinical Pearls
- 💡 **Compliance is Key**: Long-term adherence to the regimen is paramount for successful secondary prophylaxis. IM injections often improve compliance.
- 💡 **Duration Varies**: Prophylaxis duration is individualized based on ARF severity and patient age; may be lifelong.
- 💡 **Injection Site Pain**: Benzathine Penicillin G IM can be painful; administer slowly and consider warming the vial to body temperature.
- 💡 **Oral Option**: Penicillin V is an effective oral alternative for secondary prophylaxis but requires strict adherence.
> **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.